AARD
Aardvark Therapeutics, Inc.
5.60$
-0.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3.8% | -92.0% | +2,300.0% | +81.3% | – | – | – | – | +0.0% | +10.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +59.4% | -21.5% | +233.8% | +0.9% | +98.3% | -3.8% | +69.5% | +4.5% | +4.1% | +15.9% | -36.9% | – | |
| – | -2.4% | +64.0% | +135.8% | -49.5% | +35.3% | +95.6% | -0.4% | +46.7% | +11.1% | +33.9% | -21.5% | – | |
| – | +29.9% | -2.8% | +179.7% | -16.2% | +85.6% | +10.8% | +51.4% | +11.7% | +5.7% | +20.1% | -32.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.